UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 205449
---------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: March 6, 2000
OMNICOMM SYSTEMS, INC.
----------------------
(Name of Small Business Issuer in its charter)
DELAWARE 0-26028 11-3349762
-------- ------- ----------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Indet. No.)
3250 MARY STREET, SUITE 402, MIAMI, FLORIDA 33133
-------------------------------------------------
(Address of Principal Executive Offices and Zip code)
Registrant's Telephone number: (305)448-4700
<PAGE>
Items 1, 2, 5, AND 6.
---------------
On February 14, 2000, OmniComm Systems, Inc., a Delaware corporation
("OmniComm"), entered into a preliminary agreement to acquire 25% of the current
stock equity of Medical Network EMN Ltd. for cash and restricted common stock of
OmniComm.
Item 7 EXHIBITS.
--------
(c) Exhibits.
99 Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned duly authorized.
Date: March 6, 2000 OMNICOMM SYSTEMS, INC.
----------------------
(Registrant)
By: /s/ PETER S. KNEZEVICH
--------------------------------
Peter S. Knezevich
Chief Executive Officer
<PAGE>
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
- ----------- -----------
99 Press Release
EXHIBIT 99
3250 Mary Street
Suite 402
Miami, FL 33133
Main number: 305-448-4700
Fax: 305-448-4757
www.omnicomm.com
For Immediate Release
OmniComm Acquires Strategic Position in
European Medical Network
European Site Attracts Doctors, Increasing OmniComm's Global Reach
MIAMI--March 7, 2000--OmniComm Systems, Inc. (OTC BB: OMCM), a provider of
online clinical trial solutions for the pharmaceutical and healthcare
industries, today announced that it has acquired a substantial interest in the
European Medical Network (EMN), a leading destination for the European medical
industry. This agreement reflects OmniComm's strategy to substantially expand
its presence on a global basis. OmniComm will pay cash and stock for the
position in EMN.
"OmniComm is focused on expanding its network to link more doctors to relevant
patient studies that are conducted by pharmaceutical companies," said Peter
Knezevich, CEO of OmniComm Systems, Inc. "This alliance with EMN will give us
access to leading medical authorities and doctors in Europe, the second largest
clinical trial market in the world.
The European Medical Network is a pan-European destination site providing
doctors with continuing medical education (CME) information. EMN provides the
information within an evolving European regulatory framework where CME
information will become critical for doctors to maintain specialized knowledge
and skills within certain practice areas as well as being kept up to date on new
therapies and findings in medical research. Within this framework, EMN expects
to attract doctors that are likely to both participate in and provide patients
for clinical trials. Additionally, EMN has a collaborative relationship with
healthstream.com, a US based continuing medical education site.
Healthstream.com's relationship with academic medical centers and pharmaceutical
and medical device companies will expand OmniComm's reach to market TrialMaster1
and WebIPA2.
"We are pleased to have reached this partnership with OmniComm," said John
Winistoerfer of Medical Network EMN AG."Together, we will enhance the value we
bring to doctors in the European community by providing them with an easy way to
find appropriate clinical trials for patients."
<PAGE>
OmniComm will also have access to six leading European medical authorities who
serve on EMN's scientific advisory board. The influence of these medical experts
will increase the exposure of OmniComm's TrialMaster to the European medical
community. These members of the board include:
o Dr. Leonard Harvey, gynecological obstetrician and Deputy Chairman of
Committee Permanent (CP). He is the past President and current Liaison
Officer of the European Union of Medical Specialists.
o Dr. Marc Bonnel, preventive medicine expert and the Commissioner of the
Confederation des Syndicats Medicaus and the French Delegate of the
European Forum of Medical Associations.
o Prof. Dr.Heyo Eckel, radiologist and President of Aerztekammer
Nierdersachsen and Chairman of the German Senate in Charge of CME in
Germany.
o Dr. Claudio Cricelli, general practitioner and President of the European
Union of General Practitioners.
o Dr. Rene Salzberg, pediatrician and the Chairman of the Swiss Federal
Examinations Commissions for healthcare professions.
About OmniComm
OmniComm Systems, Inc. presents a total solution to the clinical trial industry
through the combination of it's medical portal, WebIPA, and its TrialMasterTM
application. WebIPA.com (WWW.WEBIPA.COM) links pharmaceutical companies with
doctors and patients worldwide, serving as a trial information destination and
exchange. The TrialMasterTM application successfully executes the three
essential functions in the clinical trial process: collection, validation and
compilation of physicians' clinical data over the Internet. With TrialMasterTM
providing these crucial, labor intensive and costly functions, trials are
completed in less time and costs are cut significantly. With these two branches,
Omnicomm has created a seamless and highly efficient solution for the clinical
trial industry, ultimately enhancing the drug and medical device approval
process, benefiting health patients worldwide. OmniComm (WWW.OMNICOMM.COM) has
offices in Miami, FL and Amsterdam.
About European Medical Network
Medical Network EMN AG- a privately held Swiss joint stock company- was formed
to create a multimedia distance-learning service for the healthcare professions
in Europe, combining broadband (satellite and cable) broadcast with a narrowband
Internet service. It recently has concluded a European-wide pilot project
supported by the European Space Agency (ESA) in cooperation with the European
Union of Medical Specialists (UEMS) and Industrial partners. EMN will offer its
subscribers a periodic menu of CME courses in different multimedia formats
(linear video, interactive, on-line forums) and currently is preparing its
operational launch.
Safe Harbor Statement
Statements about Omnicomm's future expectations, including without limitation,
future revenues and earnings, plans and objectives for the future operations,
future agreements, future economic performance, operations and all other
statements in this press release other than historical facts are
"forward-
<PAGE>
looking statements" within the meeting of Section 27A of the Securities Act of
1933, Section 21E of the Securities Exchange Act of 1934, and as that term is
defined in the Private Securities Litigation Reform Act of 1995. OmniComm
intends that such forward-looking statements be subject to the safe harbors
created thereby. Since these statements involve risks and uncertainties,
including but not limited to economic, competitive, governmental, contractual
and technological factors affecting OmniComm's operations, markets and
profitability, actual results could differ materially and adversely from the
expected results.
Contacts:
Lawton Jackson Megan Terry or Kathryn Akers
OmniComm Systems, Inc. The Abernathy MacGregor Group
Phone: 305-448-9143 Phone: 212-371-5999
e-mail: [email protected] e-mail: [email protected]
------------------- -----------------
[email protected]
- --------
1 The TrialMasterTM application successfully executes the three essential
functions in the clinical trial process: Collection of data, data assessment and
validation, and monitoring of collection accuracy. By providing these crucial,
labor intensive and costly functions, TrialMasterTM is able to complete trials
in 1/3 the time and cut 80% of the costs of trials processed. These results, in
turn, create unprecedented benefits for the doctors, pharmaceutical companies as
well as the patients involved.
2 WebIPA serves as trial information destination and portal exchange for the
pharmaceutical and healthcare industries. Omnicomm's de-unidentifiable patient
information, accessible on the WebIPA site, will directly link pharmaceutical
companies, doctors and patients.
